Waldencast plc (WALD): Financial results for H1 2026
Waldencast plc (WALD) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Waldencast plc Announces First Half 2026 Financial Results September 28, 2026 – New York, New York – Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), the parent company of Milk Makeup, the clean prestige beauty brand born from the creative community of
How this was made
The 30-second read
Why it matters
The earnings release signals a steep decline in operating performance, prompting likely short‑term price weakness.
Market read
Primary earnings disclosure for a small‑cap listed company; relevant for traders monitoring niche consumer‑goods stocks.
What to watch
Potential upside from the upcoming Milk Makeup product relaunch and reduced overhead costs.
Background
Waldencast plc (NASDAQ: WALD) is a beauty company owning Milk Makeup, recently divested its Obagi Medical business.
Ticker impact
Waldencast disclosed H1 2026 results with net revenue down 57% YoY and a net loss of $94.9 million, plus the sale of Obagi Medical for $149.9 million.
downward pressure as investors price in weaker performance and debt repayment.
The sharp revenue drop and loss, combined with a delisting plan, suggest reduced investor confidence.
Market effects
Highlights challenges in the prestige beauty segment and may affect peers with similar exposure.
Limited to U.S. and UK investors; no broader market effect.
Minimal global impact beyond niche beauty investors.
Counterpoint
The cash proceeds and debt repayment could enable a turnaround if the brand execution improves.
Key entities
- companyWaldencast plc
Parent company of Milk Makeup, listed on NASDAQ.
- buyerBridgepoint
Acquired Obagi Medical from Waldencast.

